The first ICPerMed Conference 'Personalised Medicine in Action' took place on 20-21 November 2018 in Berlin, Germany. The main focus of this conference was to present best practice examples of successful implementation of personalised medicine approaches.
-------------------------------------------------------------------------------------------------
2nd Best Practice Example of Personalised Medicine Research & Implementation - From Basic Research to the Patient: Genomic Medicine Sweden (GMS) - Acceleration of Implementation of Personalised Medicine for Rare Diseases and Cancer

Introduction and Moderation: Jan-Ingvar Jönsson, Swedish Research Council, Sweden

Different perspectives:
- The policy perspective: Jenni Nordborg, National Coordinator Office for Life Science, Sweden
- The patient’s perspective: Fabian Bolin, CEO & Co-founder, WarOnCancer AB and Sebastian Hermelin, COO & Co-founder, WarOnCancer AB, Sweden
- The company’s perspective: Joachim Reischl, AstraZeneca, Sweden
Genomics Medicine Sweden (GMS): Richard Rosenquist, Head of GMS, Sweden
- Clinical implementation of GMS: Anna Wedell, Karolinska University Hospital, Sweden
-------------------------------------------------------------------------------------------------
Read more about the conference: [ Ссылка ]

Read more about the International Consortium for Personalised Medicine (ICPerMed): [ Ссылка ]

свернуть